Appen Limited
ASX: APX
China-led growth and GenAI demand lift revenue and cash flow, with positive EBITDA guidance reaffirmed.
(Source: TradingView) 3-Month Performance Profile of APX on a DTF compared to S&P/ASX 200 (XJO).
Appen posted H1 FY25 revenue of $160.9 million, with cashflow from operations up 19.3% YoY to $20.73 million, supported by cost-saving measures and efficiency gains. Ch
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
